Elucidating Multi‐Stage Progression of Neuro‐degeneration Process in Alzheimer’s Disease

Mounting evidence shows that an individual’s neurodegeneration process exhibits wide heterogeneity in clinical manifestation. Since early symptomatic interventions may ultimately constitute the best long‐term therapeutic strategy, it is vital to disentangle the diverse neurodegeneration process into several distinct progression stages and understand the stage‐specific interaction between AD biomarkers and risk factors.